Cargando…
Designing persuasive health education for patients seeking unproven stem cell interventions
Misinformation among clinics advertising unproven stem cell interventions (SCIs) is pervasive and has resulted in patient and societal harms. Most bioethics commentaries have centered on advancing regulatory approaches to curtail the supply side of the market, but insufficient attention has been pai...
Autores principales: | Kawam, Omar, Zhu, Xuan, Eton, David T., Martin-Lillie, Charlene, Finney Rutten, Lila J., Shapiro, Shane, Tilburt, Jon C., Master, Zubin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444566/ https://www.ncbi.nlm.nih.gov/pubmed/37557072 http://dx.doi.org/10.1016/j.stemcr.2023.06.004 |
Ejemplares similares
-
How to Peddle Hope: An Analysis of YouTube Patient Testimonials of Unproven Stem Cell Treatments
por: Hawke, Bethany, et al.
Publicado: (2019) -
Preying on Public Fears and Anxieties in a Pandemic: Businesses Selling Unproven and Unlicensed “Stem Cell Treatments” for COVID-19
por: Turner, Leigh
Publicado: (2020) -
Prescribing unproven cancer drugs: physician perspectives on expanded access and right to try
por: Manley, Haley, et al.
Publicado: (2022) -
Can civil lawsuits stem the tide of direct-to-consumer marketing of unproven stem cell interventions
por: Horner, Claire, et al.
Publicado: (2018) -
The Direct to Consumer Stem Cell Market and the Role of Primary Care Providers in Correcting Misinformation
por: Arthurs, Jennifer R., et al.
Publicado: (2022)